Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis.
Siafis S, Wu H, Wang D, Burschinski A, Nomura N, Takeuchi H, Schneider-Thoma J, Davis JM, Leucht S.
Mol Psychiatry. 2023 Aug;28(8):3267-3277. doi: 10.1038/s41380-023-02203-y. Epub 2023 Aug 3.
Olanzapine for schizophrenia.
Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.
Cochrane Database Syst Rev. 2000;(2):CD001359. doi: 10.1002/14651858.CD001359.
Olanzapine for schizophrenia.
Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.
Cochrane Database Syst Rev. 2003;(1):CD001359. doi: 10.1002/14651858.CD001359.
A rating scale for extrapyramidal side effects.
Simpson GM, Angus JW.
Acta Psychiatr Scand Suppl. 1970;212:11-9. doi: 10.1111/j.1600-0447.1970.tb02066.x.
Antidopaminergic medications in Huntington's disease.
Tan AM, Geva M, Goldberg YP, Schuring H, Sanson BJ, Rosser A, Raymond L, Reilmann R, Hayden MR, Anderson K.
J Huntingtons Dis. 2025 Feb;14(1):16-29. doi: 10.1177/18796397241304312. Epub 2025 Jan 12.
Trihexyphenidyl dependence.
McInnis M, Petursson H.
Acta Psychiatr Scand. 1984 Jun;69(6):538-42. doi: 10.1111/j.1600-0447.1984.tb02528.x.
Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
Jung HY, Kim JH, Ahn YM, Kim SC, Hwang SS, Kim YS.
Hum Psychopharmacol. 2005 Jan;20(1):41-5. doi: 10.1002/hup.655.
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.
Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A; Members of the IPMDS Rating Scales Review Committee.
Mov Disord. 2023 Jun;38(6):1008-1026. doi: 10.1002/mds.29392. Epub 2023 Apr 20.
Rating scales to measure side effects of antipsychotic medication: A systematic review.
van Strien AM, Keijsers CJ, Derijks HJ, van Marum RJ.
J Psychopharmacol. 2015 Aug;29(8):857-66. doi: 10.1177/0269881115593893. Epub 2015 Jul 8.
New atypical antipsychotic medications.
Jibson MD, Tandon R.
J Psychiatr Res. 1998 May-Aug;32(3-4):215-28. doi: 10.1016/s0022-3956(98)00023-5.
